Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for leukemia and lymphoma

S W Adams1, S G Emerson

  • 1Division of Hematology/Oncology, Children's Hospital of Philadelphia, Pennsylvania, USA.

Hematology/Oncology Clinics of North America
|July 31, 1998
PubMed
Summary

Gene therapy offers four main strategies for treating malignant diseases like leukemia and lymphoma: gene interference, insertion, immunopotentiation, and suicide gene therapy. This review explores their therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of MRI T1 relaxation time with neuropsychological test performance in manganese- exposed welders.

Neurotoxicology·2017
Same author

Osteoblasts and The Hematopoietic Microenvironment.

Hematology (Amsterdam, Netherlands)·2016
Same author

The role of parathyroid hormone and insulin-like growth factors in hematopoietic niches: physiology and pharmacology.

Molecular and cellular endocrinology·2008
Same author

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.

Bone marrow transplantation·2005
Same author

Intra-tibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats.

Journal of musculoskeletal & neuronal interactions·2005
Same author

Etoposide differentially affects bone marrow and dermal derived endothelial cells.

Journal of cellular and molecular medicine·2004

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant diseases, particularly leukemias and lymphomas, present significant therapeutic challenges.
  • Gene therapy has emerged as a promising modality for cancer treatment.

Purpose of the Study:

  • To review the diverse applications of gene therapy in treating leukemias and lymphomas.
  • To categorize and discuss the primary gene therapy approaches utilized in hematologic malignancies.

Main Methods:

  • Literature review of gene therapy strategies.
  • Categorization of gene therapy into four main approaches: gene interference, gene insertion, immunopotentiation, and suicide gene therapy.
  • Analysis of the application of these approaches in preclinical and clinical studies for leukemia and lymphoma.

Main Results:

  • Gene interference strategies aim to suppress oncogene expression or activate tumor suppressor genes.
  • Gene insertion approaches focus on delivering therapeutic genes to target cancer cells.
  • Immunopotentiation involves enhancing the patient's immune system to fight cancer.
  • Suicide gene therapy utilizes genes that induce cancer cell death upon activation by a prodrug.

Conclusions:

  • The four reviewed gene therapy approaches demonstrate potential in targeting leukemias and lymphomas.
  • Further research and clinical trials are necessary to optimize efficacy and safety for widespread application.
  • Gene therapy holds significant promise for advancing the treatment landscape of hematologic malignancies.

Related Experiment Videos